LENZ Therapeutics, Inc.
LENZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001815776
No open-market purchases or sales by LENZ Therapeutics, Inc. insiders were filed in the last 90 days; 145 institutions reported holding it in 13F filings for Q2 2026, worth $197.3M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in LENZ Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 66
- +4 vs. Q3 2022
- Shares held
- 28.8M
- −815.9K (−2.8%) vs. Q3 2022
- Total value
- $95.6M
- +$1.72M (+1.8%) vs. Q3 2022
- New holders
- 13
- 21 more added
- Sold out
- 9
- 15 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LENZ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 145 | $197.3M |
| Q1 2026 | 146 | $303.3M |
| Q4 2025 | 161 | $561.6M |
| Q3 2025 | 166 | $1.36B |
| Q2 2025 | 114 | $725.1M |
| Q1 2025 | 105 | $541.8M |
| Q4 2024 | 95 | $573.2M |
| Q3 2024 | 78 | $444.8M |
| Q2 2024 | 65 | $327.0M |
| Q1 2024 | 55 | $362.0M |
| Q4 2023 | 63 | $81.5M |
| Q3 2023 | 67 | $75.8M |
| Q2 2023 | 66 | $81.2M |
| Q1 2023 | 62 | $72.9M |
| Q4 2022 | 66 | $95.6M |
| Q3 2022 | 63 | $93.9M |
| Q2 2022 | 63 | $83.0M |
| Q1 2022 | 63 | $185.7M |
| Q4 2021 | 58 | $431.7M |
| Q3 2021 | 60 | $587.4M |
| Q2 2021 | 51 | $981.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding LENZ Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 7 | $0 | 0.00% | +7 | New |
| Steward Financial Group LLC | 13 | $0 | 0.00% | +13 | New |
| State of Wyoming | 185 | $614 | 0.00% | +135+270.0% | Added |
| Federation des caisses Desjardins du Quebec | 200 | $664 | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 169 | $1.00K | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 591 | $1.96K | 0.00% | +45+8.2% | Added |
| UBS Group AG | 1,526 | $5.07K | 0.00% | 00.0% | Unchanged |
| Quantbot Technologies LP | 1,600 | $5.31K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,116 | $7.00K | 0.00% | −4,365−67.4% | Reduced |
| Lazard Asset Management LLC | 2,206 | $7.00K | 0.00% | +2,206 | New |
| Advisor Group Holdings, Inc. | 3,090 | $10.1K | 0.00% | +20+0.7% | Added |
| Simplex Trading, LLC | 3,346 | $11.0K | 0.00% | −34,791−91.2% | Reduced |
| Wells Fargo & Company | 3,353 | $11.1K | 0.00% | −195−5.5% | Reduced |
| JPMorgan Chase & Co | 3,911 | $13.0K | 0.00% | −2,359−37.6% | Reduced |
| Erste Asset Management GmbH | 11,900 | $38.3K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 13,968 | $46.4K | 0.00% | −1,605−10.3% | Reduced |
| Lodestar Private Asset Management LLC | 14,199 | $47.1K | 0.01% | +14,199 | New |
| Cannell Capital LLC | 14,308 | $47.5K | 0.01% | 00.0% | Unchanged |
| Occudo Quantitative Strategies LP | 14,833 | $49.2K | 0.01% | −8,645−36.8% | Reduced |
| Bailard, Inc. | 15,866 | $52.7K | 0.00% | −15,434−49.3% | Reduced |
| Charles Schwab Investment Management Inc | 17,740 | $58.9K | 0.00% | 00.0% | Unchanged |
| Annandale Capital, LLC | 17,930 | $60.0K | 0.02% | +17,930 | New |
| Belvedere Trading LLC | 22,121 | $73.4K | 0.04% | +22,121 | New |
| Acadian Asset Management LLC | 25,799 | $85.0K | 0.00% | +25,799 | New |
| Qube Research & Technologies Ltd | 27,103 | $90.0K | 0.00% | +7,110+35.6% | Added |
| K2 Principal Fund, L.P. | 28,424 | $94.4K | 0.03% | +28,424 | New |
| Boothbay Fund Management, LLC | 28,463 | $94.5K | 0.00% | +28,463 | New |
| Goldman Sachs Group Inc | 28,602 | $95.0K | 0.00% | −223,132−88.6% | Reduced |
| D. E. Shaw & Co., Inc. | 30,284 | $100.5K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 33,635 | $111.7K | 0.00% | +33,635 | New |
| Prelude Capital Management, LLC | 34,199 | $113.5K | 0.01% | +1,300+4.0% | Added |
| Morgan Stanley | 35,298 | $117.2K | 0.00% | +3,975+12.7% | Added |
| Dimensional Fund Advisors LP | 49,319 | $164.0K | 0.00% | +38,667+363.0% | Added |
| 683 Capital Management, LLC | 52,306 | $173.7K | 0.02% | +52,306 | New |
| Bank of America Corp | 52,539 | $174.4K | 0.00% | +14,793+39.2% | Added |
| Cornercap Investment Counsel Inc | 66,427 | $220.5K | 0.04% | 00.0% | Unchanged |
| Citigroup Inc | 71,155 | $236.2K | 0.00% | +70,358+8,827.9% | Added |
| Northern Trust Corp | 78,734 | $261.4K | 0.00% | +15,640+24.8% | Added |
| Bank of Montreal | 82,400 | $273.6K | 0.00% | +82,400 | New |
| State Street Corp | 89,151 | $296.0K | 0.00% | +41,700+87.9% | Added |
| Anson Funds Management LP | 112,176 | $358.8K | 0.12% | +112,176 | New |
| Man Group plc | 111,798 | $371.2K | 0.00% | +72,573+185.0% | Added |
| Bridgeway Capital Management, LLC | 130,500 | $433.3K | 0.01% | +17,000+15.0% | Added |
| Millennium Management LLC | 133,344 | $443.0K | 0.00% | −217,325−62.0% | Reduced |
| Cormorant Asset Management, LP | 199,547 | $662.0K | 0.04% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 208,367 | $691.8K | 0.00% | −51,961−20.0% | Reduced |
| Gsa Capital Partners LLP | 214,492 | $712.0K | 0.09% | +23,789+12.5% | Added |
| Geode Capital Management, LLC | 242,536 | $805.0K | 0.00% | +22,666+10.3% | Added |
| Oasis Management Co Ltd. | 255,102 | $846.9K | 0.18% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 255,200 | $847.3K | 0.00% | −11,200−4.2% | Reduced |
| Renaissance Technologies LLC | 329,872 | $1.09M | 0.00% | −192,097−36.8% | Reduced |
| OUP Management Co., LLC | 406,308 | $1.35M | 2.20% | 00.0% | Unchanged |
| Board of Trustees of The Leland Stanford Junior University | 459,287 | $1.52M | 0.15% | −243,784−34.7% | Reduced |
| BlackRock Inc. | 520,591 | $1.73M | 0.00% | +37,624+7.8% | Added |
| Laurion Capital Management LP | 573,600 | $1.90M | 0.05% | 00.0% | Unchanged |
| Privium Fund Management (UK) Ltd | 612,505 | $2.03M | 1.55% | +47,559+8.4% | Added |
| Artal Group S.A. | 700,000 | $2.32M | 0.13% | 00.0% | Unchanged |
| Prosight Management, LP | 916,558 | $3.04M | 1.70% | +560,113+157.1% | Added |
| Federated Hermes, Inc. | 1,058,501 | $3.51M | 0.01% | +5180.0% | Added |
| Tang Capital Management LLC | 1,100,000 | $3.65M | 0.53% | 00.0% | Unchanged |
| FMR LLC | 1,116,123 | $3.71M | 0.00% | −3,756,635−77.1% | Reduced |
| Citadel Advisors LLC | 1,190,415 | $3.95M | 0.00% | −83,632−6.6% | Reduced |
| Vanguard Group Inc | 1,226,916 | $4.07M | 0.00% | +26,634+2.2% | Added |
| Avidity Partners Management LP | 1,575,000 | $5.23M | 0.12% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 5,712,096 | $19.0M | 0.58% | +4,129,961+261.0% | Added |
| Samsara BioCapital, LLC | 8,459,314 | $28.1M | 6.05% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −848,412−100.0% | Sold out |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −577,250−100.0% | Sold out |
| New York Life Investments Alternatives | 0 | $0 | 0.00% | −25,333−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −23,600−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −12,836−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −11,542−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −10,800−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −10,530−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −312−100.0% | Sold out |
| American Portfolios Advisors | – | – | – | – | Not filed |